Featured Story

The elephant in the classroom

Biopharma needs to address its workforce training methods

PM1911 WebLeadImage 295X269

The world can’t stop talking about biopharma’s scientific achievements, but the discussion often avoids the industry’s biggest potential buzzkill: a shortage of properly trained workers to manufacture these new drugs.There’s no denying that biopharma drugs will play a vital role in the future of medicine. Biologics make up about 40 percent of the over 16,000 drugs in the global pharma pipeline. These biologic hopefuls include drugs in new therapeutic areas, such as cell and gene therapy, that are igniting the industry on fire with their potential to treat the previously untreatable. The U.S. Food and Drug Administration estimated that by 2020, they will be…

Full Story

Pharma Manufacturing Exclusives


Valuable educational content — from tutorials to reference guides —  for all pharmaceutical manufacturing professionals.

Research Zone

A collection of news stories highlighting advances in medical science and pharmaceutical R&D.

Funny Pharm

Write a caption and win!

Aug15homepageBe sure to check out our newest cartoon created by award-winning artist Jerry King. He provides the artwork; you provide the funny caption!

Most Recent

  • Product Focus: Keepin' it clean

    By Meagan Parrish, Senior Editor

    It’s no secret that contaminants are the enemy of the cleanroom. When looking for equipment to use in a contained environment, manufacturers not only need to gauge function, they also need to work with products that are easy to keep free from impurities.And although that goal is always…

    Full Story
  • The next decade of cleanrooms

    By Ronald A. Rader, Senior Director, Technical Research, BioPlan Associates

    The demand for cleanrooms used in biopharmaceutical facilities continues to grow significantly. Virtually every facility producing biologics or pharmaceuticals has at least one cleanroom. Technologies for cleanroom design and construction have changed in recent years due to increasing concerns over…

    Full Story
  • Moving beyond the last frontier of paper

    “I can tell you from someone who has been in the field as an auditor that it’s easy to go into any office and pick apart any paper-based product mostly due to human error — missing fields, unreadable documents or not having the correct version labeled,” says Bryant Headley."The big issue is…

    Full Story
  • Pharma's struggle to find balance

    By Mark Howard, U.S. Manager, EU Automation

    Historically, pharmaceutical manufacturing was a long and laborious process. The industry can be traced back to local apothecaries, where scientists would manually create and distribute botanical drugs to the community. Often, this process would require multiple people to manufacture just one…

    Full Story
  • The future of cold chain logistics

    By Mark W. Sawicki, Ph.D., Chief Commercial Officer, Cryoport

    When it comes to supply chain management, the pharmaceutical industry is characteristically conservative compared to other key industries such as automotive, aerospace and food service. This may be due to the fact that only the basic requirements for pharmaceutical distribution have been outlined…

    Full Story
  • The crux of an effective pharma recall

    By Matt Lowe, President of Labs, MasterControl

    Anytime the government moves faster than you, there’s a problem. In this case, pharmaceutical companies that hesitate to digitize may be surprised to learn that multiple regulatory agencies have digitized ahead of them. For example, the U.S. Food and Drug Administration (FDA) has not only gone…

    Full Story

Latest Products